457 related articles for article (PubMed ID: 6196852)
21. The study of local fibrinolysis in abortion.
Ikeuchi M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1215-23. PubMed ID: 2411832
[TBL] [Abstract][Full Text] [Related]
22. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
[TBL] [Abstract][Full Text] [Related]
23. Studies on activator formation in human plasma with streptokinase. III. Investigation of activator kinetics in undiluted plasma in terms of urokinase equivalents.
Martin M
Thromb Haemost; 1976 Dec; 36(3):566-81. PubMed ID: 138962
[TBL] [Abstract][Full Text] [Related]
24. [Fibrinolytic treatment of deep venous thromboses with streptokinase at an ultrahigh dosage].
Theiss W; Baumann G; Klein G
Dtsch Med Wochenschr; 1987 Apr; 112(17):668-74. PubMed ID: 3569060
[TBL] [Abstract][Full Text] [Related]
25. [Fibrinolytic treatment of 28 thromboses of valve prostheses. A biological study].
Lorient-Roudaut MF; Boisseau MR; Ledain L; Roudaut R; Besse P; Bricaud H
J Mal Vasc; 1986; 11(4):351-5. PubMed ID: 3805896
[TBL] [Abstract][Full Text] [Related]
26. Concepts of clot lysis.
Francis CW; Marder VJ
Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
[TBL] [Abstract][Full Text] [Related]
27. [Fibrinolytic treatment with urokinase and streptokinase for recurrent thrombosis in two valve prostheses for the aortic and mitral valves during pregnancy].
Tissot H; Vergnes C; Rougier P; Bricaud H; Dallay D
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1093-6. PubMed ID: 1811007
[TBL] [Abstract][Full Text] [Related]
28. A method for the measurement of fibrinolytic activity based on one dimensional diffusion using small glass tubes. II. With special reference to the differences between the use of plasminogen-rich fibrinogen and that of plasminogen-free fibrinogen as the substrates.
Yasukouchi T; Fujine M; Kohn S; Sakurama S; Morioka T
Thromb Haemost; 1977 Jun; 37(3):456-63. PubMed ID: 578026
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Moia M; Mannucci PM; Pini M; Prandoni P; Gurewich V
Thromb Haemost; 1994 Sep; 72(3):430-3. PubMed ID: 7531876
[TBL] [Abstract][Full Text] [Related]
30. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
31. Plasmin inhibitors and fibrinogen breakdown during the initial phase of thrombolytic treatment--the problem of the alpha 2-antiplasmin determination.
Noll G; Lämmle B; Duckert F
Thromb Haemost; 1984 Jul; 51(3):334-7. PubMed ID: 6238441
[TBL] [Abstract][Full Text] [Related]
32. Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro.
Onundarson PT; Haraldsson HM; Bergmann L; Francis CW; Marder VJ
Thromb Haemost; 1993 Dec; 70(6):998-1004. PubMed ID: 8165625
[TBL] [Abstract][Full Text] [Related]
33. Blood coagulation changes during effective thrombolysis using urokinase and heparin.
Schöffel G; Zimmermann R; Harenberg J; Mörl H
Thromb Res; 1982 Jan 1-15; 25(1-2):11-21. PubMed ID: 6175040
[TBL] [Abstract][Full Text] [Related]
34. Theoretic and practical considerations on laboratory monitoring of thrombolytic therapy.
Conard J; Samama MM
Semin Thromb Hemost; 1987 Apr; 13(2):212-22. PubMed ID: 3114887
[No Abstract] [Full Text] [Related]
35. [The progress of a fibrinolytic therapy with streptokinase, urokinase and warfarin in a thoroughbred with intermittent lameness with special reference to resonance thrombography].
Pause B; Nolte I; Geiss V; Mayer H; Lasch HG
Tierarztl Prax; 1988; 16(4):377-83. PubMed ID: 3222790
[TBL] [Abstract][Full Text] [Related]
36. [Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
Roncato M; Vitoux JF; Pernes JM; Aiach M; Fiessinger JN; Gaux JC; Housset E; Leclerc M
Ann Biol Clin (Paris); 1985; 43(6):851-5. PubMed ID: 3832977
[TBL] [Abstract][Full Text] [Related]
37. Intraarterial fibrinolytic therapy for popliteal and tibial artery obstruction: comparison of streptokinase and urokinase.
Traughber PD; Cook PS; Micklos TJ; Miller FJ
AJR Am J Roentgenol; 1987 Sep; 149(3):453-6. PubMed ID: 3497528
[TBL] [Abstract][Full Text] [Related]
38. The influence of L-asparaginase therapy on the fibrinolytic system.
Vellenga E; Kluft C; Mulder NH; Wijngaards G; Nieweg HO
Br J Haematol; 1984 Jun; 57(2):247-54. PubMed ID: 6203549
[TBL] [Abstract][Full Text] [Related]
39. [Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy].
Grimm W; Schwieder G; Wagner T
Dtsch Med Wochenschr; 1990 Aug; 115(31-32):1183-7. PubMed ID: 2379466
[TBL] [Abstract][Full Text] [Related]
40. Selective fibrinolytic activity of recombinant non-glycosylated human pro-urokinase (single-chain urokinase-type plasminogen activator) from bacteria.
Hanbücken FW; Schneider J; Günzler WA; Friderichs E; Giertz H; Flohé L
Arzneimittelforschung; 1987 Aug; 37(8):993-7. PubMed ID: 3118890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
